assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease.
assess the impact of albumin level on clinical course and outcomes of HE.
patients aged >18 years.
Confirmed chronic liver disease (by imaging ,
liver function tests , and clinical history).
Diagnosed with hepatic encephalopathy based on clinical criteria.
Patients age less than 18 years old
Acute liver failure.
Chronic renal failure on dialysis.
Pregnant women.
sample size calculation will be performed based on anticipated incidence rates of HE and variability in serum albumin levels, aiming for a study population of 100patients to achieve adequate statistical power.
Case-only
Prospective
Not listed
assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease.
assess the impact of albumin level on clinical course and outcomes of HE.
Click on the lead sponsor to view all of their trials.
